1. Newer cefalosporins have an increased risk of inducing immune haemolytic anaemia

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Ceftizoxime has a favourable risk: benefit ratio

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Ranitidine appears to have an exceptional safety profile

   Newsletter Article 31 January 2013 Pages: 1 - 1

4. Parents are still ignorant of the risk of aspirin-related Reye’s syndome

   Newsletter Article 31 January 2013 Pages: 2 - 2

5. Do thiazide diuretics prevent osteoporosis? Time to find out

   Newsletter Article 31 January 2013 Pages: 2 - 2

6. Use of isotretinoin in fertile women should be restricted to those with FDA-approved indications

   Newsletter Article 31 January 2013 Pages: 2 - 3

7. Alteplase/heparin/streptokinase

   Newsletter Article 31 January 2013 Pages: 3 - 3

8. Amiodarone

   Newsletter Article 31 January 2013 Pages: 3 - 3

9. Anistreplase

   Newsletter Article 31 January 2013 Pages: 3 - 3

10. BCG

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. BCG vaccine

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Beclomethasone

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Carbamazepine/phenobarbital overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Chlormezanone/fluoxetine

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Chloroquine

    Newsletter Article 31 January 2013 Pages: 4 - 5

16. Corticosteroids

    Newsletter Article 31 January 2013 Pages: 5 - 5

17. Cyclosporin

    Newsletter Article 31 January 2013 Pages: 5 - 5

18. Diazoxide

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Dideoxycytidine/dideoxyinosine

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Dideoxyinosine see Dideoxycytidine/dideoxyinosine

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Diuretics

    Newsletter Article 31 January 2013 Pages: 5 - 5

22. Epinephrine

    Newsletter Article 31 January 2013 Pages: 5 - 6

23. Epoetin

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Erythromycin

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Estradiol

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Fluconazole

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Fluoxetine see Chlormezanone/fluoxetine

    Newsletter Article 31 January 2013 Pages: 6 - 6

28. Glafenine

    Newsletter Article 31 January 2013 Pages: 6 - 6

29. Glucagon

    Newsletter Article 31 January 2013 Pages: 7 - 7

30. Granulocyte colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Granulocyte-macrophage colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. Heparin see Alteplase/heparin/streptokinase

    Newsletter Article 31 January 2013 Pages: 7 - 7

33. Immunotherapy

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Lithium

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Nilutamide

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Octreotide

    Newsletter Article 31 January 2013 Pages: 7 - 8

37. Paracetamol

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Phenobarbital see Carbamazepine/phenobarbital overdose

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Phenobarbital overdose

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Propylthiouracil

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Psoralens + ultraviolet A light

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Streptokinase see Alteplase/heparin/streptokinase

    Newsletter Article 31 January 2013 Pages: 8 - 8

43. Thioridazine overdose

    Newsletter Article 31 January 2013 Pages: 8 - 8

44. Tryptophan

    Newsletter Article 31 January 2013 Pages: 8 - 8

45. Tumour necrosis factor

    Newsletter Article 31 January 2013 Pages: 8 - 8

46. Ultraviolet A light see Psoralens + ultraviolet A light

    Newsletter Article 31 January 2013 Pages: 8 - 8